Diabetes Metab J.  2021 Jan;45(1):43-45. 10.4093/dmj.2020.0293.

The Role of Adipose Tissue Lipolysis in Diet-Induced Obesity: Focus on Vimentin

• Roh E
• Yoo HJ

• KMID: 2514072
• DOI: http://doi.org/10.4093/dmj.2020.0293

Reference

1. Nielsen TS, Jessen N, Jorgensen JO, Moller N, Lund S. Dissecting adipose tissue lipolysis: molecular regulation and implications for metabolic disease. J Mol Endocrinol. 2014; 52:R199–222.

2. Arner P. Catecholamine-induced lipolysis in obesity. Int J Obes Relat Metab Disord. 1999; 23 Suppl 1:10–3.

3. Gaidhu MP, Anthony NM, Patel P, Hawke TJ, Ceddia RB. Dysregulation of lipolysis and lipid metabolism in visceral and subcutaneous adipocytes by high-fat diet: role of ATGL, HSL, and AMPK. Am J Physiol Cell Physiol. 2010; 298:C961–71.

4. Carmen GY, Victor SM. Signalling mechanisms regulating lipolysis. Cell Signal. 2006; 18:401–8.

5. Sun K, Kusminski CM, Scherer PE. Adipose tissue remodeling and obesity. J Clin Invest. 2011; 121:2094–101.

6. Trayhurn P, Wood IS. Adipokines: inflammation and the pleiotropic role of white adipose tissue. Br J Nutr. 2004; 92:347–55.

7. Strissel KJ, Stancheva Z, Miyoshi H, Perfield JW 2nd, DeFuria J, Jick Z, et al. Adipocyte death, adipose tissue remodeling, and obesity complications. Diabetes. 2007; 56:2910–8.

8. Fabbrini E, Sullivan S, Klein S. Obesity and nonalcoholic fatty liver disease: biochemical, metabolic, and clinical implications. Hepatology. 2010; 51:679–89.

9. Fuchs E, Weber K. Intermediate filaments: structure, dynamics, function, and disease. Annu Rev Biochem. 1994; 63:345–82.

10. Shen WJ, Patel S, Eriksson JE, Kraemer FB. Vimentin is a functional partner of hormone sensitive lipase and facilitates lipolysis. J Proteome Res. 2010; 9:1786–94.

11. Hirata Y, Hosaka T, Iwata T, Le CT, Jambaldorj B, Teshigawara K, et al. Vimentin binds IRAP and is involved in GLUT4 vesicle trafficking. Biochem Biophys Res Commun. 2011; 405:96–101.

12. Kumar N, Robidoux J, Daniel KW, Guzman G, Floering LM, Collins S. Requirement of vimentin filament assembly for beta3-adrenergic receptor activation of ERK MAP kinase and lipolysis. J Biol Chem. 2007; 282:9244–50.

13. Wilhelmsson U, Stillemark-Billton P, Boren J, Pekny M. Vimentin is required for normal accumulation of body fat. Biol Chem. 2019; 400:1157–62.

14. Kim S, Kim I, Cho W, Oh GT, Park YM. Vimentin deficiency prevents high-fat diet-induced obesity and insulin resistance in mice. Diabetes Metab J. 2021; 45:97–108.

15. Su X, Abumrad NA. Cellular fatty acid uptake: a pathway under construction. Trends Endocrinol Metab. 2009; 20:72–7.

16. Zhou D, Samovski D, Okunade AL, Stahl PD, Abumrad NA, Su X. CD36 level and trafficking are determinants of lipolysis in adipocytes. FASEB J. 2012; 26:4733–42.

17. Bonen A, Tandon NN, Glatz JF, Luiken JJ, Heigenhauser GJ. The fatty acid transporter FAT/CD36 is upregulated in subcutaneous and visceral adipose tissues in human obesity and type 2 diabetes. Int J Obes (Lond). 2006; 30:877–83.

18. Hajri T, Han XX, Bonen A, Abumrad NA. Defective fatty acid uptake modulates insulin responsiveness and metabolic responses to diet in CD36-null mice. J Clin Invest. 2002; 109:1381–9.